dc.contributor.author
Liu, Qianshuo
dc.date.issued
2025-09-02T11:30:46Z
dc.date.issued
2025-09-02T11:30:46Z
dc.date.issued
2024-12-01
dc.date.issued
2025-09-02T11:30:46Z
dc.identifier
https://hdl.handle.net/2445/222896
dc.description.abstract
This paper theoretically studies pharmaceutical innovation collaborations, where heterogeneous firms compete for heterogeneous academics. At an interim stage, the firm evaluates the project, which allows it to monitor academics and decide whether to terminate the project to avoid the loss from a future failure. This paper explores the contract, project termination strategy, and collaboration matching. The firm’s innovation strategy (exploitations or explorations) determines the evaluation structure, which may affect the market equilibrium. (...)
dc.format
application/pdf
dc.publisher
Elsevier B.V.
dc.relation
Reproducció del document publicat a: https://doi.org/https://doi.org/10.1016/j.jhealeco.2024.102922
dc.relation
Journal of Health Economics, 2024, vol. 98, p. 1-21
dc.relation
https://doi.org/https://doi.org/10.1016/j.jhealeco.2024.102922
dc.rights
cc-by-nc-nd (c) Elsevier B.V., 2024
dc.rights
http://creativecommons.org/licenses/by-nd/3.0/es/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Economia)
dc.subject
Gestió de la innovació
dc.subject
Tecnologia farmacèutica
dc.subject
Avaluació de l'assistència mèdica
dc.subject
Innovation management
dc.subject
Pharmaceutical technology
dc.subject
Medical care evaluation
dc.title
Pharmaceutical Innovation Collaboration, Evaluation, and Matching
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion
